Corticosteroid-induced neuropsychiatric disorders: Review and contrast with neuropsychiatric lupus

Rheumatology International

Volumn 33, Issue 8, 2013, Pages 1923-1932

  Bhangle, Samir D ^a   Kramer, Neil ^b   Rosenstein, Elliot D ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Overlook Medical Center   (United States)

Author keywords

Affective disorder; Corticosteroids; Drug toxicity; Psychosis; Systemic lupus erythematosus

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; FLUOXETINE; HALOPERIDOL; IMATINIB; KETOCONAZOLE; LITHIUM; METHYLPREDNISOLONE; NEFAZODONE; PHENOTHIAZINE DERIVATIVE; PREDNISOLONE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGORAPHOBIA; ANTICHOLINERGIC EFFECT; ANTICONVULSANT THERAPY; ANXIETY DISORDER; ASEPTIC MENINGITIS; BEHAVIOR DISORDER; CATATONIA; CHILDHOOD DISEASE; CORTICOSTEROID THERAPY; DELIRIUM; DEMENTIA; DEPRESSION; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FATIGUE; HUMAN; HYPOMANIA; INSOMNIA; LEARNING DISORDER; LOW DRUG DOSE; MANIA; MEMORY DISORDER; MENTAL DISEASE; NEUROPSYCHIATRY; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOSIS; RESTLESSNESS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL CORTEX HORMONES; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MENTAL DISORDERS;

EID: 84880923983     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2750-z     Document Type: Review

References (91)

1. Lewis DA, Smith RE (1983) Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord 5:319-332
2. Brown ES, Suppes T (1998) Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry 5:239-246
3. Kenna HA, Poon AW, de los Angeles CP, Koran LM (2011) Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci 65:549-560
4. Clark LD, Quarton GC, Cobb S, Bauer W (1953) Further observations on mental disturbances associated with cortisone, and ACTH therapy. N Engl J Med 249:178-183
5. Ling MHM, Perry PJ, Tsuang MT (1981) Side effects of corticosteroid therapy. Arch Gen Psychiatry 18:471-477
6. Cade R, Spooner G, Schlein E, Pickering M, DeQuesada A, Holcomb A, Juncos L, Richard G, Shires D, Levin D, Hackett R, Free J, Hunt R, Fregly M (1973) Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis. Nephron 10:37-56
7. Rome HP, Braceland FJ (1952) The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am J Psychiatry 108:641-651
8. Glaser TH (1953) Psychotic reactions induced by corticotrophin (ACTH) and cortisone. Psychosom Med 15:280-291
9. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
10. Soffer LJ, Levitt MF, Baehr G (1950) Use of cortisone and adrenocorticotropic hormone in acute disseminated lupus erythematosus. Arch Intern Med 86:558-573
11. Terao T, Mizuki T, Ohji T, Abe K (1994) Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroids. Br J Psychiatry 164:109-111
12. Baker M, Hadler NM, Whitaker JN, Dunner DL, Gerwin RD, Decker JL (1973) Psychopathology in systemic lupus erythematosus: II: relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4. Semin Arthr Rheum 3:111-126
13. Jones BD, Chouinard G (1985) Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus. Am J Psychiatry 142:354-355
14. Naber D, Sand P, Heigl B (1996) Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment: a prospective study. Psychoneuroendocrinology 21:25-31
15. Patten SB, Williams JVA, Love EJ (1996) Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics. Int J Psychiatry Med 26:15-24
16. Patten SB, Williams JVA, Love EJ (1995) Self-reported depressive symptoms in association with medication exposures among medical inpatients: a cross-sectional study. Can J Psychiatry 40:264-269
17. Palinkas LA, Wingard DL, Barrett-Connor E (1990) Chronic illness and depressive symptoms in the elderly: a population-based study. J Clin Epidemiol 43:1131-1141
18. Rundell JR, Wise MG (1989) Causes of organic mood disorder. J Neuropsychiatry Clin Neurosci 1:398-400
19. Minden SL, Orav J, Schildkraut JJ (1988) Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 38:1631-1634
20. Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, Akiyama K, Kuroda S (2001) Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 42:461-466
21. Mullen RS, Romans-Clarkson SE (1993) Behavioral sensitization and steroid-induced psychosis. Br J Psychiatry 162:549-551
22. Greeves JA (1984) Rapid onset steroid psychosis with very low dosage of prednisolone. Lancet I:1119-1120
23. Turktas I, Gucuyener K, Ozden A (1997) Medication-induced psychotic reaction. J Am Acad Child Adolesc Psychiatry 36:1017-1018
24. Hall RCW, Popkin MK, Stickney SK, Gardner ER (1979) Presentation of the steroid psychoses. J Nerv Ment Dis 167:229-236
25. Patten SB, Neutel I (2000) Corticosteroid-induced adverse psychiatric effects. Drug Saf 22:111-122
26. Lidz T, Carter JD, Lewis BI, Surratt C (1952) Effects of ACTH and cortisone on mood and mentation. Psychosom Med 24:363-377
27. Perényi A, Frecska E, Bagdy G, Révai K (1988) Panic attacks as a consequence of chronic corticosteroid therapy? Eur J Psychiatry 2:69-74
28. Cameron OG, Addy RO, Malitz D (1985) Effects of ACTH and prednisone on mood: incidence and time of onset. Int J Psychiatry Med 15:213-223
29. Grigg JR (1989) Prednisone mood disorder with associated catatonia. J Geriatr Psychiatry Neurol 2:41-44
30. Sullivan BJ, Dickerman JD (1979) Steroid associated catatonia: report of a case. Pediatrics 63:677-679
31. Varney NR, Alexander B, MacIndoe JH (1994) Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 141:369-372
32. Harris JC, Carel CA, Rosenberg LA, Joshi P, Leventhal BG (1986) Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences. J Am Acad Child Adolesc Psychiatry 1:120-124
33. Hall TC, Choi OS, Abadi A, Krant MJ (1967) High-dose corticosteroid therapy in Hodgkin's disease and other lymphomas. Ann Intern Med 66:1144-1153
34. Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81:1361-1367
35. Freyberg RH, Traeger CH, Patterson M, Squires W, Adams CH (1951) Problems of prolonged cortisone treatment for rheumatoid arthritis. JAMA 147:1538-1543
36. Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S (1997) Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann NY Acad Sci 823:81-96
37. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D (1990) Cognitive effects of corticosteroids. Am J Psychiatr 147:1297-1303
38. Dixon R, Christy N (1980) On the various forms of corticosteroid withdrawal syndrome. Am J Med 68:224-230
39. Lewis A, Fleminger JJ (1954) The psychiatric risk from corticotrophin and cortisone. Lancet i:383-386
40. Brown ES, Suppes T, Khan DA, Carmody TJ (2002) Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol 22:55-61
41. Wada K, Yamada N, Suzuki H, Lee Y, Kuroda S (2000) Recurrent cases of corticosteroid induced-mood disorders: clinical characteristics and treatment. J Clin Psychiatry 61:261-267
42. Bunim JJ, Ziff M, McEwen C (1955) Evaluation of prolonged cortisone therapy in rheumatoid arthritis: a four year study. Am J Med 18:27-40
43. Nielson JB, Drivsholm A, Fischer F, Brochner-Mortensen K (1963) Long term treatment with corticosteroids in rheumatoid arthritis. Acta Med Scand 173:177-183
44. Heyreh SS, Watson PG (1970) Prednisolone-21-stearoylglycolate in scleritis. Br J Ophthalmol 54:394-398
45. Kershner P, Wang-Cheng R (1989) Psychiatric side effects of steroid therapy. Psychosomatics 30:135-139
46. Boston Collaborative Drug Surveillance Program (1972) Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13:694-698
47. Bender BG, Lerner JA, Kollasch E (1988) Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry 27:720-725
48. Sharfstein SS, Sack DS, Fauci AS (1982) Relationship between alternate day corticosteroid therapy and behavioral abnormalities. JAMA 248:2987-2989
49. Glynne-Jones R, Vernon CC, Bell G (1986) Is steroid psychosis preventable by divided doses. Lancet ii:1404
50. Wysenbeek AJ, Leibovici L, Zoldan J (1990) Acute central nervous system complications in patients after pulse steroid therapy in patients with systemic lupus erythematosus. J Rheumatol 17:1695-1696
51. Wollheim FA (1984) Acute and long-term complications of corticosteroid pulse therapy. Scand J Rheumatol 54(suppl):27-32
52. Frey BM, Frey FJ (1990) Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 19:126-146
53. Finkenbine R, Gill HS (1997) Case of mania due to prednisone- clarithromycin interaction. Can J Psychiatry 42:778
54. Wolkowitz OM, Burke H, Epel ES, Reus VI (2009) Glucocorticoids: mood, memory, and mechanisms. Ann NY Acad Sci 1179:19-40
55. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496-500
56. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, Valdez CR, Escalante A, del Rincón I, Gronseth G, Rhine CB, Padilla P, McGlasson D (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58:1214-1220
57. Kohen M, Asherson RA, Gharavi AE, Lahita RG (1993) Lupus psychosis: differentiation from the steroid-induced state. Clin Exp Rheumatol 11:323-326
58. Hanly JG, Su L, Farewell V, McCurdy G, Fougere L, Thompson K (2009) Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 36:1449-1459
59. Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G (2011) Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthr Rheum 41:1-11
60. McCune WJ, Golbus J (1988) Neuropsychiatric lupus. Rheum Dis Clin North Am 14:149-167
61. Hanly JG, Liang MH (1997) Cognitive disorders in systemic lupus erythematosus: epidemiologic and clinical issues. Ann NY Acad Sci 823:60-68
62. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthr Rheum 42:599-608
63. Appenzeller S, Cendes F, Costallat LT (2008) Acute psychosis in systemic lupus erythematosus. Rheumatol Int 28:237-243
64. Pego-Reigosa JM, Isenberg DA (2008) Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatology 47:1498-1502
65. Matsukawa Y, Sawada S, Hayama T, Usui H, Horie T (1994) Suicide in patients with systemic lupus erythematosus: a clinical analysis of seven suicidal patients. Lupus 3:31-35
66. Abdel-Nasser AM, Ghaleb RM, Mahmoud JA, Khairy W, Mahmoud RM (2008) Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin Rheumatol 27:1377-1385
67. Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F, Finamore L, Pascucci S, Gasparini M, Laganà B, Caccavo D, Ferri GM, Amoroso A, Francia A (2003) Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 61:108-110
68. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30:985-992
69. Fong KY, Thumboo J (2010) Neuropsychiatric lupus: clinical challenges, brain-reactive autoantibodies and treatment strategies. Lupus 19:1399-1403
70. Zandman-Goddard G, Chapman J, Shoenfeld Y (2007) Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthr Rheum 36:297-315
71. Sibbitt WL, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD (1989) Magnetic resonance and computed tomography imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 48:1014-1022
72. Khoshbin S, Glanz BI, Schur PH (1999) Neuropsychiatric syndromes in systemic lupus erythematosus: a new look. Clin Exp Rheumatol 17:395-398
73. Rhiannon JJ (2008) Systemic lupus erythematosus involving the nervous system: presentation, pathogenesis, and management. Clin Rev Allergy Immunol 34:356-360
74. Denburg SD, Carbotte RM, Denburg JA (1994) Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthr Rheum 37:1311-1320
75. Boumpas DT, Yamada H, Patronas NJ, Scott D, Klippel JH, Balow JE (1991) Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med 81:975-984
76. Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG (1995) Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 98:32-41
77. Ramos PC, Mendez MJ, Ames PR, Khamashta MA, Hughes GR (1996) Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol 14:295-299
78. Baca V, Lavalle C, García R, Catalán T, Sauceda JM, Sánchez G, Martínez I, Ramírez ML, Márquez LM, Rojas JC (1999) Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 26:432-439
79. Sergent JS, Lockshin MD, Klempner MSL, Lipsky BA (1975) Central nervous system disease is systemic lupus erythematosus: therapy and prognosis. Am J Med 58:644-654
80. Chau SY, Mok CC (2003) Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology 61:104-107
81. Nishimura K, Harigai M, Omori M, Sato E, Hara M (2008) Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroimmunology 33:395-403
82. Joffe RT, Denicoff KD, Rubinow DR, Tsokos G, Balow JE, Pillemer SE (1988) Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus. Gen Hosp Psychiatry 10:56-60
83. Falk WE, Mahnke MW, Poskanzer DC (1979) Lithium prophylaxis of corticotrophin-induced psychosis. JAMA 241:1011-1012
84. Blazer DG, Petrie WM, Wilson WP (1976) Affective psychosis following renal transplant. Dis Nerv Syst 128:1467-1473
85. Abbas A, Stryra R (1994) Valproate prophylaxis against steroid induced psychosis. Can J Psychiatry 39:188-189
86. Bloch M, Gur E, Shalev A (1994) Chlorpromazine prophylaxis of steroid-induced psychosis. Gen Hosp Psychiatry 16:42-44
87. Davis JM, Leach A, Merk BS, Janicak PG (1992) Treatment of steroid psychosis. Psychiatr Ann 22:487-491
88. Wyszynski AA, Wyszynski B (1993) Treatment of depression with fluoxetine in corticosteroid-dependent central nervous system Sjögren's syndrome. Psychosomatics 34:173-177
89. Brown ES, Khan DA, Suppes T (1999) Treatment of corticosteroid induced mood changes with olanzapine. Am J Psychiatry 156:968
90. Dasilva CC, Murse MC, Vokey K (2002) Steroid induced psychosis treated with risperidone. Can J Psychiatry 47:388-389
91. Ularntinon S, Tzuang D, Dahl G, Shaw RJ (2010) Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. Pediatrics 125:1241-1245